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Received April 9, 2014; accepted May 14, 2014AbstractIntracranial dural arteriovenous fistulas (DAVFs) are abnormal arteriovenous communications within the dura locating near a major venous
sinus and are supplied by pachymeningeal arteries. DAVFs represent 10e15% of all intracranial arteriovenous malformations. The natural
history and clinical manifestations are determined by location of the DAVFs and their angioarchitecture. Aggressive DAVF is usually associated
with leptomeningeal venous drains or reflux. It may present with hemorrhagic or nonhemorrhagic stroke. The goal of embolization of DAVFs is
total fistula occlusion without interfering with the normal duraevenous drains. Embolization can be performed by transarterial and/or trans-
venous routes or direct puncture of affected dural sinus. Selection of embolic materials depends on access route and angioarchitecture of the
fistula. With the involution of endovascular devices, embolic materials, and high-quality angiography, endovascular embolization of DAVFs has
been proved a safe and effective method of treating these complex cerebrovascular lesions.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Dural arteriovenous fistulas (DAVFs) can occur in any
intracranial dural regions, most commonly in the cavernous
sinus or transverse-sigmoid sinus.1e3 DAVFs are usually fed
by dural branches of the external carotid artery. The etiology
of DAVFs is not fully understood; some are congenital and
others are acquired, but most are thought to be acquired.
Different etiologies have been implicated including throm-
bosis, trauma, or surgery or in the postpartum period.4e6 Pa-
tients may be asymptomatic or may experience symptoms
ranging from mild symptoms to fatal hemorrhage.7e11 DAVFs
have been classified to benign type with dural sinus drain orConflicts of interest: The authors declare that there are no conflicts of interest
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reflux which may associate with hemorrhage or non-
hemorrhagic neurologic deficits.12e14 Management of DAVFs
includes open surgery, radiosurgery, embolization, or com-
bined treatment. In this article, we will discuss the method of
embolization, with emphasis on the access routes, embolic
materials, and individual DAVF embolization.
2. Symptoms, natural history, and classification of
intracranial DAVFs
The clinical presentations of DAVF are variable, depending
on the location of the shunt and angioarchitecture of the
shunting flow. These symptoms include exophthalmos, bruit,
cranial nerve deficits, tinnitus, hemorrhagic or non-
hemorrhagic neurological deficits, increased intracranial
pressure, papilledema, and cerebrospinal fluid reabsorption
abnormalities resulting in ventricular enlargement or conges-
tive heart failure. Several classification systems have been
developed to grade the risks and natural course of DAVFs.ociation. All rights reserved.
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most widely used. All these classifications emphasize the fis-
tula venous drains. DAVFs with antegrade dural sinus drains
and only association with sinus reflux usually present with
benign symptoms. By contrast, DAVFs with retrograde lep-
tomeningeal cortical venous drainage channel show a signifi-
cantly high rate of aggressive symptoms such as hemorrhagic
and nonhemorrhagic neurologic clinical manifestation.
Although DAVF location is not directly correlated with
aggressive behavior, the propensity for dangerous drainage
patterns found at initial diagnosis does vary with location.
3. Goal of embolization of DAVFs
The treatment strategy of DAVFs should be tailored indi-
vidually to patients considering the angioarchitecture, natural
history of the DAVFs, and the severity of symptoms. The
definitive treatment of DAVFs requires the occlusion of the
arteriovenous shunt without interfering with the normal
venous drains. Treatment can be performed by conventional
open neurosurgery, radiosurgery, or endovascular emboliza-
tion, or a combination of these modalities. The first reported
series of embolization cases was by Halbach et al in the
1980s.17 With the development of newer techniques and
embolic materials in the field of interventional neuroradiology,Fig. 1. A 61-year-old woman presented with consciousness change. (A) Brain com
ventricular systems; subdural hematoma was found as well; (B, C) left carotid angio
tentorium; (D) the patient underwent transarterial (middle meningeal artery) n
demonstrated total fistula occlusion.endovascular therapy has now been developing as the primary
treatment strategy to manage DAVFs, particularly in high-risk
DAVFs, reserving surgery only if endovascular techniques fail
or are unfeasible. The goal of embolization is to achieve an
angiographic cure by obliteration of all feeders and proximal
draining veins with preservation of the patency of the affected
sinus. In those difficult and complex DAVFs with a difficulty
of achieving total occlusion of the fistula, the goal of embo-
lization is to achieve partial treatment with reversal of the
aggressive type of DAVF to benign type, to facilitate subse-
quent radiosurgery or neurosurgery.18e20 Embolization should
usually fulfill the following requirements. If a sinus is
occluded or severely stenosed, treatment should be directed to
reestablish sinus patency21,22; if that fails, sinus occlusion with
angiographic cure of DAVF is considered. If there is a func-
tional venous pathway that was not previously occluded, it
should not be sacrificed. Treatment should not induce redi-
rection of flow to other cortical veins.
4. Embolization access routes
There are three embolization routes to manage DAVFs:
transarterial embolization (TAE) of arterial feeders (Figs. 1
and 2), transvenous embolization (TVE; Figs. 3 and 4) or
direct puncture of the affected sinus. Selective TAE requiresputed tomography demonstrated intracerebral hemorrhage with extension to
grams depicted Cognard type IV dural arteriovenous fistulas at the left posterior
-butyl-2-cyanoacrylate embolization; and (E) postembolization angiograms
Fig. 2. A 61-year-old man presented with limb weakness and diplopia. (A, B) Left carotid angiograms demonstrated Cognard type IV left tentorium dural
arteriovenous fistulas; and (CeE) the patient underwent transarterial Onyx embolization. Postembolization carotid angiogram showed total fistula occlusion.
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of the feeding artery, with delivery of the embolic material
through a feeding artery to the shunt and then into the most
proximal venous outlet. Although some studies have shown
good outcome with low complication rates for occluding
DAVFs via a transarterial route using liquid embolic
agents,23e26 this route may not always be feasible, because of
multiple, small, and tortuous feeders. Furthermore, some risks
may occur by inadvertent embolization of carotid or vertebral
territory with ischemic stroke via dangerous anastomosis of
the externaleinternal carotid artery or vertebral artery anas-
tomoses or embolization of feeders of cranial nerves. In
addition, proximal occlusion of feeding artery allows the
persistent arterial flow and recruitment of collateral blood
supply; therefore recurrence is likely. Furthermore, embolic
material migration to the venous site may result in venous
occlusion exacerbating venous hypertension. In the past, to
achieve an angiographic cure with complete fistula occlusion,
TVE with coil packing of the affected dural sinus was
selected. This technique is logical as long as the diseased
segment of the sinus is occluded completely or does not
participate in normal venous return. However, TVE is not al-
ways feasible in cases with difficult fistula anatomy, such as in
isolated or high-grade stenotic dural sinus. Embolization of
DAVFs by direct puncture of affected sinus via transorbital
(e.g., cavernous sinus)27e29 or via craniotomy (e.g., lateral,
superior sagittal sinus, or sinus confluence)30e32 has beenreported, with promising results. The advantages of trans-
craniectomy access are ease of fistula access after direct sur-
gical exposure, ease of direct sinus coil packing in a small
craniectomy, and ability to performed embolization without
any intradural surgical manipulation. The disadvantage of this
access route is the potential complication of craniectomy,
including blood loss or infection. Generally, the affected sinus
should be in a superficial location close to the cranium, iso-
lated, and near another sinus. Direct puncture to access the
affected sinus is an alternative. Because of the procedure's
inherent invasiveness, it has only been considered when
endovascular routes fail based on angioarchitecture analysis.
In some complex DAVFs, a combination of TAE and TVE is
considered.
5. Selection of embolic materials
Different embolic materials have been used. These include
n-butyl-2-cyanoacrylate (NBCA; Codman, Raynham, MA,
USA), particles (polyvinyl alcohol; PVA), Onyx (eV3; Neu-
rovascular Inc., Irvine, CA, USA) or detachable coils. Coils
usually are selected for transvenous occlusion of an affected
nonfunctional dural sinus. TAE with PVA usually does not
produce a durable cure, therefore, it can only be used as a
supplement to eliminate residual minimal flow after emboli-
zation, to induce thrombosis of residual fistula, or for palliative
management of benign DAVFs. NBCA is a cheap, fast embolic
Fig. 3. An 82-year-old man had Cognard type IIb right transverse-sigmoid sinus dural arteriovenous fistula and presented with seizures. (A, B) Left common
carotid angiograms revealed aggressive dural arteriovenous fistulas with cortical reflux; occlusion of left sigmoid sinusejugular vein was found as well; and (CeE)
the patient underwent transvenous coil packing of the affected sinus. Postembolization angiograms demonstrated total fistula occlusion.
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to occlude DAVFs transarterially.33e36 Because NBCA is a
liquid adhesive, this procedure requires a highly experienced
operator with the ability to determine the appropriate con-
centration of NBCA (about 20e25%). The major disadvan-
tages of NBCA are short injection time (within minutes) and
limited amount of NBCA mixture injection leading to insuf-
ficient embolization and lower cure rate (30e50%).34e36 The
angiographic occlusion rate is statistically higher with Onyx
compared with NBCA.33 Another concern is that it is difficult
to control NBCA flow after injection, resulting in proximal
arterial occlusion in highly concentrated NBCA or migration
to a draining vein, resulting in a risk of venous infarction or
hemorrhage in low-concentrated NBCA. Onyx, a nonadhesive
liquid embolic system, consists of ethylene vinyl alcohol as
the embolic material, dimethyl sulfoxide as the solvent to
deliver ethylene vinyl alcohol, and tantalum powder for
radiographic visualization. Onyx was initially introduced in
1999 to treat brain arteriovenous malformation. In 2006, the
first case of a DAVF successfully occluded by Onyx was re-
ported.24 Subsequently, other case reports and case series were
published.25,26,37,38 Onyx provides advantages by the ability to
perform a slow, controlled injection. Injection of larger
amounts of Onyx can result in filling of the fistulous network
and allow for reflux into other arterial feeders in a single
feeder embolization. The development of Onyx was amilestone in the endovascular treatment of DAVF, with
promising results with a relatively high morphologic cure rate
of 62.5e80%.25,26,37,38 However, there are some disadvan-
tages of Onyx. The long-term patency of Onyx embolization is
unknown. Onyx itself may leave microchannels within the cast
that allow a small fistula of flow, resulting in recurrence after
endovascular embolization. In addition, Onyx has been
thought to cause significant inflammation within the vascula-
ture, particularly with treatment of cavernous carotid fistulas
in which the surrounding cranial nerves are often irritated,
resulting in various cranial nerve palsies.
6. Embolization of individual DAVFs6.1. Transverseesigmoid sinus DAVFsThe transverseesigmoid sinus (TSS) represents the most
common location for DAVFs. Spontaneous regression of TSS
DAVFs is uncommon and usually occurs following hemor-
rhagic events.39 The arterial supply originates from the dural
branches of the occipital artery, middle meningeal artery,
ascending pharyngeal artery, and/or dural branches of the
vertebral artery or tentorial branches of the meningohypo-
physeal trunk. Although their most common symptoms are
benign (e.g., pulsatile tinnitus and headache), TSS DAVFs
may present with hemorrhagic and nonhemorrhagic aggressive
Fig. 4. A 53-year-old man had left cavernous sinus dural arteriovenous fistula and presented with chemosis and proptosis. (A, B) Pre-embolization carotid an-
giograms showed cavernous sinus dural arteriovenous fistula fed by dural branches of the left carotid arteries with exclusive drainage to the ophthalmic vein; (C)
the patient underwent transvenous coil packing of left cavernous sinus via facial vein; and (D, E) postembolization carotid angiograms demonstrated total fistula
occlusion.
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require treatment because of the low rate of spontaneous
regression without symptomatic events and the relatively high
rate of aggressive symptoms. The selection of endovascular
management of TSS DAVFs depends on the patient's symp-
toms and angioarchitecture analysis. If patients present with
benign DAVFs with functional antegrade TSS drainage, TAE
with preservation of the patency of the TSS and symptomatic
treatment is the first choice. In those aggressive TSS DAVFs
with leptomeningeal venous drainage/ reflux, the goal of
treatment is total occlusion of the DAVFs by TAE or TVE.
Transvenous coil packing of the affected TSS is usually safe
and highly effective if the affected sinus does not participate in
normal TSS venous return. Angiographic cure can be achieved
in 80e100% of patients.39e41 This procedure requires sacrifice
of sinus flow, therefore, occlusion of the nearby normal
antegrade cortical venous drainage should be avoided. The
rate of permanent complications is approximately 4%.39e41
Transarterial access by liquid embolic materials is selected
for those patients with functionally affected TSS or failure to
access by transvenous route. The reported cure rate for using
TAE with NBCA is approximately 60%.1 Recently, TAE with
ONYN has replaced the NBCA as the first choice of liquid
embolic material because of better morphologic cure. The cure
rate may be up to 100% in some selected patients.42 Anotheroption for managing TSS DAVFs with high-grade stenosis or
occlusion is endovascular stent placement. Recanalization,
angioplasty, and stenting of stenosis/occlusive TSS can restore
antegrade sinus flow and close shunts within the sinus wall,
however, only a few successful cases have been reported.21,22
Further investigation of the effectiveness of stent placement in
the treatment of DAVFs is necessary.6.2. Cavernous sinus DAVFsCavernous sinus (CS) DAVF represents the second most
common location for DAVFs; it usually occurs in middle-aged
women and is fed by multiple small dural branches of the
internal and/or external carotid arteries. Because of their slow-
flow shunts, some CS DAVFs have a tendency to undergo
spontaneous thrombosis, observed in 10e50% of cases.43
Regarding management of CS DAVFs, if patients present
with mild clinical symptoms with no angiographic risk of
hemorrhagic or nonhemorrhagic neurologic deficits, conser-
vative treatment, or a less invasive procedure such as obser-
vation, manual compression of the carotid artery,44 or
radiosurgery45 can be applied. If patients have pial reflux and/
or are at risk of clinical deterioration such as gradual loss of
visual acuity or cranial nerve palsy, embolization is required.
The most common symptoms of CS DAVFs AVF are ocular
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venous drainage; posterior drainage to inferior or superior
petrous sinus may lead to bruit or cranial nerve palsy or reflux
to cerebellar veins; superior drainage to superficial middle
cerebral vein may occasionally have a risk of impairment of
local cerebral venous drain. Aggressive neurologic symptoms
such as intracranial hemorrhage are extremely rare; inferior
drains to the pterygoid plexus may lead to bruit or nasal
congestion. Transvenous coil packing of affected CS has been
proved to be an effective and safe method to manage the CS
DAVF. The cure rate varied from 80% to 100%.46 However,
dense packing of the CS with coils should be avoided because
of the risk of cranial nerve deficits due to coil compression.
There are many transvenous routes to reach the CS, and these
include the inferior petrous sinus, basilar plexus, facial vein,
angular vein, and superior ophthalmic vein, or through the
pterygoid plexus. Recently, TAE with Onyx of CSDAVFs has
been performed, with better morphologic outcomes than those
treated by NBCA. However, embolization via the middle
meningeal artery with occlusion of blood flow to facial or
trigeminal nerve has been reported. Another concern is the
migration of Onyx cast to the pial artery via dangerous
anastomoses leading to ischemic stroke and/or blindness. On
rare occasions with aggressive CS DAVF, in which there is
failure to access via the endovascular route, a transorbital
approach is an alternative. Successful treatment of geometri-
cally difficult CS DAVF by transorbital direct puncture of the
ophthalmic vein or anterior CS under fluoroscopic guidance
has been reported.28e30 The potential risks of these procedures
include orbital hemorrhage, injury to the optic nerve or other
cranial nerves in the CS, globe puncture, and infection.
Therefore, the operator should be familiar with orbital anat-
omy and equipped with high-quality digital subtraction
angiography.6.3. Tentorial DAVFsTentorial DAVFs represent 4e8% of all intracranial fis-
tulas.1,47,48 Because tentorial DAVFs drain only via the lep-
tomeningeal vein, they carry a high risk of aggressive
neurologic symptoms. The reported aggressive clinical
behavior in 79e92% of cases,12,16,48 the occurrence of intra-
cranial hemorrhage is about 70%14; in some cases, this hem-
orrhage consists of fatal bleeding in the posterior fossa. The
arterial supply mainly comes from the tentorial artery, such as
dural branches of the meningohypophyseal trunk and/or
middle meningeal artery. Venous drainage is usually through
the superior petrosal sinus or through the pontine, peri-
mesencephalic, and basal veins into the Galenic system.
Because of the aggressive behavior of tentorial DAVFs, the
goal of embolization is total fistula occlusion. In the past, TAE
was effective by using NBCA occlusion of the proximal
draining vein, whereas TVE with coils was preferred when the
lesion was anatomically suited.48 Now, TAE with deposition
of liquid embolic material such as NBCA or Onyx to occlude
the fistula is commonly selected. The angiographic cure rate
by TAE with Onyx is better than that for treatments withNBCA. Huang et al49 reported 12 patients presenting with
intracranial hemorrhage who were treated by Onyx emboli-
zation. Complete cure was achieved in 11 patients. All of the
patients recovered well, except one who died of severe
infection caused by ventricular drainage.6.4. Superior sagittal sinus DAVFsSuperior sagittal sinus (SSS) DAVFs represent approxi-
mately 3e8% of all intracranial DAVFs.1,15 They are
frequently associated with restrictive drainage of the SSS and
retrograde cortical venous drainage, therefore, aggressive
neurologic symptoms are seen in 50% of cases. The reported
bleeding rate of SSS DAVFs is about 15e40%.1,15,50 Venous
congestion and ischemia of the bilateral frontal lobes due to
SSS DAVFs can cause dementia. These fistulas are usually
supplied by dural branches of bilateral middle meningeal ar-
teries and/or the anterior falcine artery from the ophthalmic
arteries. Therefore, SSS DAVFs commonly possess multi-
plicity in arterial feeders and critical venous drainage. Endo-
vascular management of SSS DAVFs is similar to that for
treating TSS DAVFs. However, SSS DAVFs are more
frequently associated with hemorrhagic and nonhemorrhagic
stroke and therefore often require aggressive treatment. TVE
with coil packing of affected SSS is the first choice if the SSS
is not functional for normal cortical vein drainage. Neverthe-
less, SSS DAVFs are usually associated with SSS occlusion or
stenosis; the TVE is often difficult. In cases with difficult
access via the transvenous route, or if the SSS has participated
in normal venous drainage, TAE with NBCA or Onyx is
indicated; however, the feeders of meningeal arteries are
usually distally and tortuously located, leading to difficulty in
navigating the microcatheter to the fistula site. TAE with oc-
clusion of feeding arteries is commonly associated with
insufficient embolization, with fistula recurrence by recruit-
ment of the feeders. In the past, TAE using NBCA was
selected to achieve angiographic cure or as an adjunct therapy
for subsequent radiosurgery or open surgery. Recently, NBCA
was replaced by Onyx as a transarterial embolizer because of
better angiographic and clinical outcomes. Chai et al51 re-
ported four cases in which successful angiographic cure was
achieved with Onyx via TAE.6.5. Anterior cranial fossa DAVFsAnterior cranial fossa DAVFs constitute rare lesions, repre-
senting < 10% of all DAVFs.52 DAVFs located on the anterior
fossa drain through the retrograde leptomeningealecortical
venous drainage system only, associating with a high risk of
hemorrhagic or nonhemorrhagic aggressive symptoms. The
occurrence of intradural hemorrhage is about 84%15; therefore,
a complete angiographic cure is necessary. The arterial supply is
mainly from the posterior and anterior ethmoidal branches of
the ophthalmic arteries. They may also recruit supply from the
ethmoidal branches of the external carotid artery. Because there
is no dural sinus in this area, themain venous drainage is into the
frontal cortical veins and secondarily into the SSS. In the past,
616 C.-B. Luo et al. / Journal of the Chinese Medical Association 77 (2014) 610e617this type of fistula was considered as difficult for endovascular
treatment, as the supplying vessels are small and tortuous,
precluding catheterization with current technology. By contrast,
surgical approaches are relatively easy and safe. When TAE
with selective catheterization through the ophthalmic artery is
performed, it is paramount to verify that the microcatheter tip is
located beyond the origin of the central retina artery to avoid
complications such as stroke and blindness. Few anterior fossa
DAVFs can be safely treated with TVE, because transvenous
routes are also tortuous and often associated with venous an-
eurysms. However, this approach is more complicated and
rarely used when treating this type of DAVF. Some authors
strongly oppose embolization as it poses numerous technical
difficulties and represents more costly treatment. Since the
advertent of Onyx, TAE with angiographic cure has become
feasible.52,53 Li et al52 successfully managed 10 out of 11 cases
with Onyx embolization. No signs of rebleeding or symptom
progression were observed at a mean follow-up of 18.5 months.6.6. Other DAVFsDAVFs can also occur at other intracranial locations,
including the marginal sinus, inferior and superior petrosal
sinuses, major sinus wall, and hypoglossal canal. TVE by coil
packing dural sinus is preferred if the affected sinus is
nonfunctional and does not participate the normal venous
drains. TAE by using Onyx to manage these DAVFs is indi-
cated when the feeder is accessible.
In conclusion, endovascular management of DAVFs in-
cludes a number of options with varying risk and effectiveness
for individual lesions. TAE, TVE, or direct puncture can be
used depending on angioarchitecture and individual clinical
scenarios. Endovascular management of DAVFs is a proven
safe and effective method of treating these complex cerebro-
vascular lesions.
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